Cocrystal Pharma Inc

NASDAQ:COCP   10:12:34 AM EDT
1.17
+0.09 (+8.33%)
Earnings Announcements

Cocrystal Pharma Reports 2020 Financial Results, Provides Business Update Including Antiviral Program Milestones

Published: 03/17/2021 13:12 GMT
Cocrystal Pharma Inc (COCP) - Cocrystal Pharma Reports 2020 Financial Results, Provides Business Update Including Antiviral Program Milestones.
Cocrystal Pharma Inc - Reported $33.1 Million in Cash and Cash Equivalents As of December 31, 2020, Compared With $7.4 Million As of December 31, 2019.
Revenue is expected to be $0.6 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $0.55 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.